Uracil-DNA glycosylase pseudogene 3 (UNGP3)

Uracil-DNA glycosylase pseudogene 3 (UNGP3) is annotated as a *pseudogene* and not a functional protein-coding gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they arise from gene duplication or retrotransposition, losing their ability to produce active proteins. In this case, UNGP3 is a non-coding sequence related to *uracil-DNA glycosylase* (UNG), an enzyme responsible for removing uracil from DNA and a crucial component in the base excision DNA repair pathway[1][2][4]. However, **UNGP3 itself is not transcribed into an active enzyme nor does it participate directly in any metabolic or signaling pathways**. There are no known drugs, mechanisms of action, biomarker roles, or disease associations for this pseudogene. - The **canonical functional gene** in this family is called **Uracil-DNA glycosylase (UNG)**, which has a well-documented enzymatic and therapeutic relevance[1][2][4]. - **UNGP3** does not encode a protein and is not considered a therapeutic target. Its presence in nomenclature or gene databases reflects gene annotation conventions, not biological or pharmacological activity. - Searching standard scientific databases for "UNGP3" yields no entries suggesting it functions in any biological or disease context, nor is it referenced in therapeutics or biomarker strategies. If the intention was to refer to the active enzyme (**Uracil-DNA glycosylase**, UNG), additional information is available—but for "uracil-DNA glycosylase pseudogene 3," it is not a relevant target for drug discovery or therapeutic development.